Bergenin attenuates osteoclast-mediated bone loss by modulating the SIRT1/NF-κB p65 signalling axis

Published: 30 July 2026| Version 1 | DOI: 10.17632/hr7w7gd4k3.1
Contributor:
驹 CHEN

Description

the molecular docking of bergenin, SIRT1 and p65

Files

Categories

Osteoclast, Osteoporosis

Licence